The WHO Chemical Risk Assessment Network Community of Trainers - Webinars on how to design a training in Chemical Risk Assessment
Looking to the future: The Rockefeller Foundation and WHO identify priorities for global health collaboration
Palliative care interventions in UHC compendium
Update on Omicron
Streets for Life campaign presented with Prince Michael International Road Safety Award
Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern
WHO publishes updated guidance on validation of elimination of mother-to-child transmission of HIV, syphilis and hepatitis B virus
Onchocerciasis elimination: achieving NTD road map targets, despite current pandemic challenges
FIFA supports World Health Organization 16-day campaign to raise awareness on domestic violence
Gender based violence is a public health issue: using a health systems approach
Interim statement on COVID-19 vaccination for children and adolescents
First meeting of Scientific Advisory Group for the Origins of Novel Pathogens (SAGO)
What’s new in the TB section of the 2021 WHO Model Lists of Essential Medicines
WHO releases HIV drug resistance report 2021
Quality assurance of gender-based violence health services in Bangladesh
Statement of the Thirtieth Polio IHR Emergency Committee
WHO issues guidelines on the treatment of children with multisystem inflammatory syndrome associated with COVID-19
WHO and MPP announce the first transparent, global, non-exclusive licence for a COVID-19 technology
The Netherlands affirms its position as a leading flexible contributor to WHO
Gonorrhoea: latest antimicrobial global surveillance results and guidance for vaccine development published
U.S. EPA and WHO partner to protect public health
COVAX delivers its 1 billionth COVID-19 vaccine dose
WHO recommends two new drugs to treat COVID-19
Draft Intersectoral global action plan on epilepsy and other neurological disorders 2022–2031
Interim Statement on COVID-19 vaccines in the context of the circulation of the Omicron SARS-CoV-2 Variant from the WHO Technical Advisory Group on COVID-19 Vaccine Composition (TAG-CO-VAC)
Message for World Leprosy Day 2022
WHO psychological intervention effective in preventing mental disorders among Syrian refugees in Turkey
International Men’s Day 2021: Enabling a Gender-sensitive Response to End TB
Together on the road to evidence-informed decision-making for health in the post-pandemic era: new EVIPNet Call for Action
WHO Global Evidence-to-Policy (E2P) Summit: Three days for the systematic use of evidence-informed decision-making in health policy and practice
New Food Safety Community of Practice will help share knowledge and improve practice
Achieving 70% COVID-19 Immunization Coverage by Mid-2022
Launch of the WHO Bulletin theme issue on behavioural science
From vaccines to vaccinations: seventh meeting of the Multilateral Leaders Task Force on COVID-19 Vaccines, Therapeutics and Diagnostics
Interim statement on booster doses for COVID-19 vaccination
Animation film illustrating the six components required for assessing the development of palliative care
US FDA approved cabotegravir extended-release – the first long-acting injectable option for HIV pre-exposure prophylaxis
Medical Product Alert N°9/2021: Falsified Soliris
Medical Product Alert N°8/2021: Falsified Combiart
Behavioural considerations for acceptance and uptake of COVID-19 vaccines